Previous studies reported that the clinical symptoms and laboratory indicators of RA patients could be significantly improved by DJD, including the duration of morning stiffness, the number of joint tenderness, the level of erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor.[11–14] In addition, many researchers had argued that DJD therapy had fewer adverse reactions than routine disease-modifying antirheumatic drugs (rDMARDs).[15–18] Accordingly, DJD is considered an important complementary and alternative therapy for the treatment of RA. Here, CRP is linked to rheumatoid arthritis.